AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6947990 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatment (instruction and practice in oral hygiene techniques and meticulous prophylaxis) repeated every 2-3 months
Number of subjects: 555
Study 6947990 — intervention group
Group type: COMPARATOR
Intervention: Traditional dental care (control group)
Number of subjects: 555
Study 30612892 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional balance training using visual feedback
Number of subjects: 24
Study 27684425 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral colostrum priming (OCP)
Number of subjects: 99
Study 27684425 — intervention group
Group type: COMPARATOR
Intervention: No oral colostrum priming (Control)
Number of subjects: 99
Study 25930097 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear EUS
Number of subjects: 278
Study 25930097 — intervention group
Group type: COMPARATOR
Intervention: Radial EUS
Number of subjects: 278
Study 25930097 — intervention group
Group type: EXPERIMENTAL
Intervention: Second EUS examination
Number of subjects: 278
Study 25930097 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 278
Study 23757082 — intervention group
Group type: EXPERIMENTAL
Intervention: One 1‐hour on‐site clinician education session followed by 1 year of personalized, quarterly audit and feedback of prescribing for bacterial and viral ARTIs
Number of subjects: 162
Study 23757082 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 162
Study 21366943 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline (HS) and 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 135
Study 19647715 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset net (2% permethrin treated long-lasting insecticidal net)
Number of subjects: 0
Study 19647715 — intervention group
Group type: COMPARATOR
Intervention: Untreated net
Number of subjects: 0
Study 19647715 — intervention group
Group type: COMPARATOR
Intervention: No net area
Number of subjects: 0
Study 17804989 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study 17804989 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 30
Study 15484347 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk distal polyps (size > or = 10 mm, or > or = 3 adenomas, or villous component > 20 percent, or severe dysplasia)
Number of subjects: 426
Study 15484347 — intervention group
Group type: COMPARATOR
Intervention: Low-risk distal polyps (1-2 tubular adenomas, < 10 mm, with low-grade dysplasia, or hyperplastic polyp)
Number of subjects: 426
Study 15484347 — intervention group
Group type: COMPARATOR
Intervention: Low-risk distal polyps (6 to 9 mm)
Number of subjects: 426
Study 15484347 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk distal polyps
Number of subjects: 426
Study 11977312 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum copper (Cu) level in measles patients during acute period
Number of subjects: 26
Study 11977312 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum copper (Cu) level in measles patients during convalescence (3 weeks after regression of clinical symptoms)
Number of subjects: 26
Study 11977312 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy persons aged 15-19)
Number of subjects: 26
Study 9043506 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter Valve (CV)
Number of subjects: 18
Study 9043506 — intervention group
Group type: COMPARATOR
Intervention: Leg-Bag (LB)
Number of subjects: 18
Study 7837153 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Takayasu's arteritis
Number of subjects: 0
Study 7837153 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody to purified 38-kDa protein of M. tuberculosis
Number of subjects: 0
Study 7837153 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody to 65-kDa HSP of M. leprae
Number of subjects: 0
Study 7837153 — intervention group
Group type: COMPARATOR
Intervention: Control group (tuberculosis positive controls, normal donors, patients with Wegener's granulomatosis)
Number of subjects: 0
Study 2905991 — intervention group
Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg
Number of subjects: 6
Study 2905991 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg
Number of subjects: 6
Study 2905991 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study 30080735 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 586
Study 30080735 — intervention group
Group type: COMPARATOR
Intervention: Control (without FS)
Number of subjects: 586
Study 27765912 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX
Number of subjects: 342
Study 27765912 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 342
Study 25049140 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural activation treatment (up to 12 sessions)
Number of subjects: 40
Study 22652535 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended daily diafiltration (EDDF)
Number of subjects: 7
Study 20524719 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin/fenofibric acid 20 mg/135 mg
Number of subjects: 474
Study 20524719 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin/fenofibric acid 10 mg/135 mg
Number of subjects: 474
Study 20524719 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin/fenofibric acid 5 mg/135 mg
Number of subjects: 474
Study 20524719 — intervention group
Group type: COMPARATOR
Intervention: simvastatin 40 mg
Number of subjects: 474
Study 18581961 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 20
Study 18581961 — intervention group
Group type: COMPARATOR
Intervention: Laparotomic surgery
Number of subjects: 20
Study 16463989 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 0
Study 16463989 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 0
Study 12209085 — intervention group
Group type: COMPARATOR
Intervention: No maintenance medications
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater severity of asthma
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopy (increased IgE and allergy skin test reactivity)
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive skin test response to dog and high level of dog allergen in the home
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive skin test response to cat and high level of cat allergen in the home
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean daily symptom code and use of albuterol for asthma symptoms
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean daily symptom code and daily use of albuterol
Number of subjects: 1041
Study 12209085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean evening peak flow percentage of personal best
Number of subjects: 1041
Study 10604095 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography assessment of external anal sphincter
Number of subjects: 32
Study 10604095 — intervention group
Group type: EXPERIMENTAL
Intervention: Defaecographic findings
Number of subjects: 32
Study 7565455 — intervention group
Group type: EXPERIMENTAL
Intervention: HOSS Ca (900 mg Ca/day)
Number of subjects: 58
Study 7565455 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (900 mg Ca/day)
Number of subjects: 58
Study 7565455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 2187614 — intervention group
Group type: EXPERIMENTAL
Intervention: Reformulated Dioralyte (RD)
Number of subjects: 32
Study 2187614 — intervention group
Group type: COMPARATOR
Intervention: Standard Dioralyte (SD)
Number of subjects: 32
Study 6156321 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin A1 (PGA1) infusion at 1/microgram/kg/min during water loading
Number of subjects: 10
Study 6156321 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin A1 (PGA1) infusion at 1/microgram/kg/min during water deprivation
Number of subjects: 10
Study 6156321 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin A1 (PGA1) infusion with hypertonic mannitol during water deprivation
Number of subjects: 10
Study 31937251 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel telephone-delivered intervention involving educational aspects for patients and information-based intervention for physicians.
Number of subjects: 0
Study 31937251 — intervention group
Group type: COMPARATOR
Intervention: Usual care (historical control group).
Number of subjects: 0
Study 31937251 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel telephone-delivered intervention.
Number of subjects: 0
Study 30277455 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental Cr (0.05 mg Cr as Cr-methionine/kg of BW0.75)
Number of subjects: 48
Study 30277455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplemental Cr)
Number of subjects: 48
Study 28317678 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 34
Study 28317678 — intervention group
Group type: COMPARATOR
Intervention: PRK
Number of subjects: 34
Study 28317678 — intervention group
Group type: COMPARATOR
Intervention: PRK with higher preoperative HOAs
Number of subjects: 34
Study 28317678 — intervention group
Group type: COMPARATOR
Intervention: PRK with lower preoperative HOAs
Number of subjects: 34
Study 27236602 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 IU gonadotropins
Number of subjects: 95
Study 27236602 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 IU gonadotropins
Number of subjects: 95
Study 27236602 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU gonadotropins plus letrozole
Number of subjects: 95
Study 24697948 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer SES
Number of subjects: 1192
Study 24697948 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer SES
Number of subjects: 1192
Study 22314121 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-formulated diclofenac 18 mg
Number of subjects: 30
Study 22314121 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-formulated diclofenac 35 mg
Number of subjects: 30
Study 19147724 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrullinated myelin detection using (1)H-MR spectroscopy in patients with MS
Number of subjects: 27
Study 19147724 — intervention group
Group type: COMPARATOR
Intervention: Normal-appearing white matter (NAWM) in patients with MS
Number of subjects: 27
Study 19147724 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic demyelinating lesions (CDLs) in patients with MS
Number of subjects: 27
Study 17504894 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide (up to 240 microg, self-administered via sc injection three times a day for 16 weeks)
Number of subjects: 204
Study 17504894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 15608387 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) to common whelk
Number of subjects: 1700
Study 15608387 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE detection by ELISA
Number of subjects: 1700
Study 15608387 — intervention group
Group type: EXPERIMENTAL
Intervention: ELISA inhibition test
Number of subjects: 1700
Study 15608387 — intervention group
Group type: EXPERIMENTAL
Intervention: IgE-immunoblotting
Number of subjects: 1700
Study 11680663 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent on-line predilution hemodiafiltration (IHDF)
Number of subjects: 39
Study 11680663 — intervention group
Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 39
Study 11680663 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IHDF and IHD
Number of subjects: 39
Study 11680663 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall hospital mortality
Number of subjects: 39
Study 9842252 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2% eye drops, one drop each eye, four times daily for 8 weeks
Number of subjects: 35
Study 7855939 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 20
Study 7855939 — intervention group
Group type: COMPARATOR
Intervention: Linsidomine chlorhydrate (SIN‐1)
Number of subjects: 20
Study 2775153 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive‐behaviour therapy (ICBT)
Number of subjects: 45
Study 2775153 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive‐behaviour therapy (GCBT)
Number of subjects: 45
Study 2775153 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WLC)
Number of subjects: 45
Study 2775153 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive‐behaviour therapy (ICBT) vs Group cognitive‐behaviour therapy (GCBT)
Number of subjects: 45
Study 799975 — intervention group
Group type: EXPERIMENTAL
Intervention: Diftalone 500 mg per day
Number of subjects: 32
Study 799975 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 75 mg per day
Number of subjects: 32
Study 31664441 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe energy restriction (65%-75%) for 4 months followed by moderate energy restriction (25%-35%) for 8 months
Number of subjects: 101
Study 31664441 — intervention group
Group type: COMPARATOR
Intervention: Moderate energy restriction (25%-35%) for 12 months
Number of subjects: 101
Study 28826627 — intervention group
Group type: EXPERIMENTAL
Intervention: PENFS (percutaneous electrical nerve field stimulation)
Number of subjects: 115
Study 28826627 — intervention group
Group type: COMPARATOR
Intervention: Sham (no electrical charge)
Number of subjects: 115
Study 24838782 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruence Couple Therapy (CCT) for 12 weeks
Number of subjects: 30
Study 24838782 — intervention group
Group type: COMPARATOR
Intervention: Control group (three brief check-ins over 12 weeks)
Number of subjects: 30
Study 23062489 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (50mg daily for 3 months)
Number of subjects: 48
Study 23062489 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 48
Study 21320954 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment (ET)
Number of subjects: 370
Study 21320954 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM)
Number of subjects: 370
Study 18664712 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg of methylphenidate
Number of subjects: 138
Study 18664712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 16438758 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg morphine
Number of subjects: 54
Study 16438758 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg sufentanil
Number of subjects: 54
Study 15178178 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in semantic association to a stimulus during trials using fMRI and PET
Number of subjects: 0
Study 10757456 — intervention group
Group type: EXPERIMENTAL
Intervention: cold solution (2-3 degrees C)
Number of subjects: 10
Study 10757456 — intervention group
Group type: EXPERIMENTAL
Intervention: hot solution (55-58 degrees C)
Number of subjects: 10
Study 10757456 — intervention group
Group type: EXPERIMENTAL
Intervention: room temperature solution (20-21 degrees C)
Number of subjects: 10
Study 10757456 — intervention group
Group type: COMPARATOR
Intervention: lactose solution (50 g)
Number of subjects: 10
Study 9351617 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.6 mg twice a day)
Number of subjects: 71
Study 9351617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 1609547 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908 Salmonella typhi vaccine strain (5 x 10(7) organisms with sodium bicarbonate)
Number of subjects: 0
Study 1609547 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908 Salmonella typhi vaccine strain (5 x 10(4) to 5 x 10(7) organisms with sodium bicarbonate)
Number of subjects: 0
Study 4047872 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Intensification and Progressive Decrease in Intensification of stimulation
Number of subjects: 81
Study 4047872 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation of series without objective stimuli
Number of subjects: 81
Study 4047872 — intervention group
Group type: EXPERIMENTAL
Intervention: All items of the scale
Number of subjects: 81
Study 4047872 — intervention group
Group type: EXPERIMENTAL
Intervention: Scale of Sensory Suggestibility
Number of subjects: 81
Study 31937608 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile closed-loop control (CLC) system
Number of subjects: 127
Study 31937608 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 127
Study 28708716 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol-320 (iso-osmolar group)
Number of subjects: 389
Study 28708716 — intervention group
Group type: COMPARATOR
Intervention: Iomeprol-370 (low-osmolar group)
Number of subjects: 389
Study 26911400 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone (10 mg/ml)
Number of subjects: 14
Study 26911400 — intervention group
Group type: COMPARATOR
Intervention: Verapamil (2.5 mg/ml)
Number of subjects: 14
Study 25002723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m(2) once per week with 60 Gy radiation and cetuximab once per week
Number of subjects: 238
Study 25002723 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 15 mg/m(2) once per week with 60 Gy radiation and cetuximab once per week
Number of subjects: 238
Study 25002723 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin arm versus control from RTOG-9501 trial
Number of subjects: 238
Study 25002723 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel arm versus control from RTOG-9501 trial
Number of subjects: 238
Study 22612007 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited open carpal tunnel release using direct vision and tunneling technique (group A)
Number of subjects: 28
Study 22612007 — intervention group
Group type: COMPARATOR
Intervention: Standard open carpal tunnel release (group B)
Number of subjects: 28
Study 20955444 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg b.d.
Number of subjects: 7
Study 20955444 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg b.d.
Number of subjects: 7
Study 20955444 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg od before breakfast
Number of subjects: 7
Study 20955444 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg od before breakfast
Number of subjects: 7
Study 20955444 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg od before dinner or at bedtime
Number of subjects: 7
Study 18572351 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mL of 10% dextran-40
Number of subjects: 20
Study 18572351 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 16138948 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable defibrillators
Number of subjects: 0
Study 16138948 — intervention group
Group type: EXPERIMENTAL
Intervention: Device therapy
Number of subjects: 0
Study 12436372 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoids and non-steroidal antirheumatic drugs (NSAD)
Number of subjects: 0
Study 12436372 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARDs (methotrexate, leflunomide, hydroxy/chloroquine, sulfasalazine)
Number of subjects: 0
Study 12436372 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-alpha-inhibiting drugs (etanercept, infliximab)
Number of subjects: 0
Study 11147027 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 micrograms Fluticasone propionate (FP) twice daily for 3 months
Number of subjects: 30
Study 11147027 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 30
Study 9176748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleurally instilled mitoxantrone (30 mg)
Number of subjects: 29
Study 8245082 — intervention group
Group type: EXPERIMENTAL
Intervention: New blunt taperpoint needle
Number of subjects: 69
Study 8245082 — intervention group
Group type: COMPARATOR
Intervention: Standard cutting needle
Number of subjects: 69
Study 3988967 — intervention group
Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 36
Study 3988967 — intervention group
Group type: EXPERIMENTAL
Intervention: doxepin
Number of subjects: 36
Study 3988967 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 31356580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia (34-35°C)
Number of subjects: 370
Study 31356580 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36.5-37.5°C)
Number of subjects: 370
Study 29208550 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage surgery
Number of subjects: 30
Study 27229685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (PPSV23)
Number of subjects: 125
Study 27229685 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine (2011-2012 trivalent seasonal)
Number of subjects: 125
Study 24763885 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (Diet M)
Number of subjects: 306
Study 24763885 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyunsaturated fat hypocaloric diet (Diet P)
Number of subjects: 306
Study 22902977 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring diaries in a weight loss program
Number of subjects: 50
Study 22902977 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-monitoring diaries)
Number of subjects: 50
Study 19765700 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS Normal-Weight (NW)
Number of subjects: 43
Study 19765700 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS Obese (Ob)
Number of subjects: 43
Study 19765700 — intervention group
Group type: COMPARATOR
Intervention: Control Normal-Weight (NW)
Number of subjects: 43
Study 19765700 — intervention group
Group type: COMPARATOR
Intervention: Control Obese (Ob)
Number of subjects: 43
Study 19765700 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS
Number of subjects: 43
Study 18765046 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 80